BioXcel Therapeutics(BTAI) - 2023 Q4 - Annual Report

| --- | --- | --- | |----------------------|-----------|------------------------------------------------| | | | | | | Trading | Name of exchange on which registered | | class | Symbol(s) | | | $0.001 per share | BTAI | Nasdaq Capital Market | TABLE OF CONTENTS This Annual Report on Form 10-K also contains estimates, projections and other information concerning our industry, our business, and the markets for certain diseases, including data regarding the estimated size of those markets, and the incidence and ...